Identifying newborns at risk of significant hyperbilirubinaemia: A comparison of two recommended approaches

Archives of Disease in Childhood

Volumn 90, Issue 4, 2005, Pages 415-421

  Keren, R ^a   Bhutani, V K ^c   Luan, X ^b   Nihtianova, S ^a   Cnaan, A ^b   Schwartz, J S ^c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b Mercy Hospital of Philadelphia   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; OXYTOCIN;

ACCURACY; ARTICLE; BILIRUBIN BLOOD LEVEL; BIRTH WEIGHT; BOTTLE FEEDING; BREAST FEEDING; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN JAUNDICE; NOMOGRAM; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SCREENING; UNITED STATES; VACUUM EXTRACTION;

COHORT STUDIES; FEMALE; HOSPITALS, COMMUNITY; HOSPITALS, TEACHING; HOSPITALS, URBAN; HUMANS; HYPERBILIRUBINEMIA; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PENNSYLVANIA; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 16844363972     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2004.060079     Document Type: Article

References (26)

1. Joint Commission on Accreditation of Healthcare Organizations. Kernicterus threatens healthy newborns. http://www.jcaho.org/about+us/ news+letters/sentinel+event+alert/sea_18.htm (accessed 25 August 2004).
2. AAP Subcommittee on Neonatal Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.
3. Newman TB, Xiong B, Gonzales VM, et al. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 2000;154:1140-7.
4. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6-14.
5. Maisels MJ, Gifford K. Normal serum bilirubin levels in the newborn and the effect of breast-feeding. Pediatrics 1986;78:837-43.
6. Gale R, Seidman DS, Dollberg S, et al. Epidemiology of neonatal jaundice in the Jerusalem population. J Pediatr Gastroenterol Nutr 1990;10:82-6.
7. Linn S, Schoenbaum SC, Monson RR, et al. Epidemiology of neonatal hyperbilirubinemia. Pediatrics 1985;75:770-4.
8. Newman TB, Escobar GJ, Gonzales VM, et al. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics 1999;104(5 pt 2):1198-203.
9. Moyer VA, Ahn C, Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med 2000;154:391-4.
10. Furnival GM, Wilson RW. Regressions by leaps and lraunds. Technometrics 1974;16:499-511.
11. SAS. SAS/STAT user's guide, version 8. Cary, NC, 1999.
12. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87.
13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
14. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
15. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley and Sons, Inc, 1989.
16. Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 2001;108:31-9.
17. Chou SC, Palmer RH, Ezhuthachan S, et al. Management of hyperbilirubinemia in newborns: measuring performance by using a benchmarking model. Pediatrics 2003;112(6 pt 1):1264-73.
18. Newman TB, Escobar GJ, Liljestrand P. Combining laboratory and clinical data for prediction of hyperbilirubinemia in newborns. Pediatr Res 2003;53:2259.
19. Chew WC. Neonatal hyperbilirubinaemia: a comparison between prostaglandin E2 and oxytocin inductions. BMJ 1977;2:679-80.
20. Chew WC, Swann IL. Influence of simultaneous low amniotomy and oxytocin infusion and other maternal factors on neonatal jaundice: a prospective study. BMJ 1977;1:72-3.
21. Davies DP, Gomersall R, Robertson R, et al. Neonatal jaundice and maternal oxytocin infusion. BMJ 1973;3:476-7.
22. Colder AA, Ounsted MK, Moar VA, et al. Increased bilirubin levels in neonates after induction of labour by intravenous prostaglandin E2 or oxytocin. Lancet 1974;2:1339-42.
23. Wood B, Culley P, Roginski C, et al. Factors affecting neonatal jaundice. Arch Dis Child 1979;54:111-15.
24. Lo SF, Doumas BT, Ashwood ER. Performance of bilirubin determinations in US laboratories-revisited. Clin Chem 2004;50:190-4.
25. Vreman HJ, Verter J, Oh W, et al. Interlaboratory variability of bilirubin measurements. Clin Chem 1996;42(6 pt 1):869-73.
26. Zhang J, Bowes WA Jr. Birth-weight-for-gestational-age patterns by race, sex, and parity in the United States population. Obstet Gynecol 1995;86:200-8.